XU Jingyu, TANG Qian, QIAN Jing, SHI Weihua, HU Tao, GAO Jianqing. Technical Risk Considerations of Manufacturing Site Changes of Chemical Solid Oral Dosage[J]. Chinese Journal of Modern Applied Pharmacy, 2022, 39(5): 690-694. DOI: 10.13748/j.cnki.issn1007-7693.2022.05.021
    Citation: XU Jingyu, TANG Qian, QIAN Jing, SHI Weihua, HU Tao, GAO Jianqing. Technical Risk Considerations of Manufacturing Site Changes of Chemical Solid Oral Dosage[J]. Chinese Journal of Modern Applied Pharmacy, 2022, 39(5): 690-694. DOI: 10.13748/j.cnki.issn1007-7693.2022.05.021

    Technical Risk Considerations of Manufacturing Site Changes of Chemical Solid Oral Dosage

    • Drug manufacturing site change is the most complicated situation which may combine with changes of formulation, supplier of active pharmaceutical ingredients and excipients, manufacturing process, process parameters, batch, and other registration administration matters. The article discussed the technical risk considerations of chemical solid oral dosage of manufacturing site changes and described the relationship between critical quality attributes and critical process parameters or key control indicators according to specific examples, which in order to provide reference and inspiration for how to carry out research when pharmaceutical manufacturers change their production sites.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return